Where is Commense located?

Commense is headquartered in Boston, United States.

How many employees does Commense have?

As of Jul 01, 2024, the latest employee count at Commense is 2.

Where does Commense rank among its competitors?

Commense ranks 72nd amongst 103 active competitors, of which 28 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Infinant Health, which secured $39.2M in May, 2026.

Who are the top competitors of Commense?

Commense's top competitors include Novozymes, Ironwood Pharma and Seres Therapeutics. Among them, Infinant Health secured the most recent funding round in May, 2026.

Commense - 2026 Company Profile, Team, Funding & Competitors

Commense is a deadpooled company based in Boston (United States), founded in 2016 by Aleks Radovic-Moreno. It operates as an Online pharmacy offering medications without prescription, focusing on various health needs. The company has 103 active competitors, including 28 funded and 16 that have exited. Its top competitors include companies like Novozymes, Ironwood Pharma and Seres Therapeutics.

Company Details

Online pharmacy offering medications without prescription, focusing on various health needs. It provides a wide array of products including pills for ADHD, antibiotics, antidepressants, birth control, blood pressure, diet, erectile dysfunction, pain relief, pet care, sleeping aids, and testosterone. The platform aims to offer solutions for common health issues, such as erectile dysfunction, birth control, and blood pressure management, alongside medications for abortion, ADHD, depression, and infections. It emphasizes accessibility and convenience in obtaining medications, providing detailed information on various treatments and conditions. The service includes options for both brand-name and generic drugs, ensuring customer privacy through discreet packaging. The business model focuses on direct-to-consumer access to pharmaceuticals, addressing a range of health and wellness needs.

Website: commensehealth.com
Social
Email ID: *****@commensehealth.com

Key Metrics

Founded Year

2016

Location

Boston, United States

Stage

Deadpooled

Investors

PureTech Health

Ranked

72^nd among 103 active competitors

Employee Count

2 as on Jul 01, 2024

Similar Companies

Novozymes & 130 more

View Commense's full profile

Commense is a funded company. Commense has 1 institutional investor.

View details of Commense's funding rounds and investors

The founders of Commense is Aleks Radovic-Moreno.

Here are the details of Commense's key team members:

Aleks Radovic-Moreno: Co-Founder of Commense and founder of 3 other companies, Ghostly, Be Bio and Be Biopharma.
Contact Info: 1 email address

View details of Commense's Founder profiles and Board Members

Commense's employee count trend

Commense has 2 employees as of Jul 24. Here is Commense's employee count trend over the years:

Uncover Commense's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Commense include Novozymes, Ironwood Pharma and Seres Therapeutics. Here is the list of Top 10 competitors of Commense, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novozymes 2000, Bagsvaerd (Denmark), Acquired	Developer of biosolutions and enzymes for multiple industries and applications of biotechnology	$9.75M	DOE, CHV & 3 others	73/100
2nd	Ironwood Pharma 1998, Cambridge (United States), Public	Developer of therapeutics for gastrointestinal disorders	$206M	Athyrium Capital Management, Maverick Ventures ... & 15 others	64/100
3rd	Seres Therapeutics 2010, Cambridge (United States), Public	Developer of microbiome therapeutics to treat a wide range of diseases	$134M	Flagship Pioneering, Mayo Clinic Business Accelerator ... & 8 others	60/100
4th	Infinant Health 2011, Norwalk (United States), Series C	Microbiome-based products to improve infant immune system	$39.2M	iSelect Fund, Gates & 4 others	60/100
5th	Biocodex 1953, Gentilly (France), Unfunded	Manufactures a range of health supplements and pharmaceuticals	-	-	59/100
6th	Oragenics 1996, Tampa (United States), Public	Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health	-	Third Security, Precigen & 3 others	58/100
7th	Genome & Company 2015, Seongnam-si (South Korea), Public	Developer of microbiome-based immuno-oncology drugs	-	IMM Investment, Timefolio Capital & 8 others	55/100
8th	Resbiotic 2021, Birmingham (United States), Series A	Provider of probiotic supplements to improve health	$20.6M	Timberline, Biostack Ventures & 3 others	55/100
9th	Nextbiotix 2016, Dijon (France), Series A	Developer of probiotic for the treatment of inflammatory bowel diseases	$30.4M	Crescent Enterprises, UI Investissement & 10 others	55/100
10th	Holobiome 2015, Cambridge (United States), Series A	Developer of microbiome-based therapeutics for nervous system disorders	$25.6M	iSelect Fund, paceventures.xyz & 13 others	55/100
72nd	Commense 2016, Boston (United States), Deadpooled	Online pharmacy offering medications without prescription, focusing on various health needs	-	PureTech Health	24/100